Towards predicting the lung fibrogenic activity of nanomaterials: experimental validation of an in vitro fibroblast proliferation assay

BackgroundCarbon nanotubes (CNT) can induce lung inflammation and fibrosis in rodents. Several studies have identified the capacity of CNT to stimulate the proliferation of fibroblasts. We developed and validated experimentally here a simple and rapid in vitro assay to evaluate the capacity of a nanomaterial to exert a direct pro-fibrotic effect on fibroblasts.MethodsThe activity of several multi-wall (MW)CNT samples (NM400, the crushed form of NM400 named NM400c, NM402 and MWCNTg 2400) and asbestos (crocidolite) was investigated in vitro and in vivo. The proliferative response to MWCNT was assessed on mouse primary lung fibroblasts, human fetal lung fibroblasts (HFL-1), mouse embryonic fibroblasts (BALB-3T3) and mouse lung fibroblasts (MLg) by using different assays (cell counting, WST-1 assay and propidium iodide PI staining) and dispersion media (fetal bovine serum, FBS and bovine serum albumin, BSA). C57BL/6 mice were pharyngeally aspirated with the same materials and lung fibrosis was assessed after 2 months by histopathology, quantification of total collagen lung content and pro-fibrotic cytokines in broncho-alveolar lavage fluid (BALF).ResultsMWCNT (NM400 and NM402) directly stimulated fibroblast proliferation in vitro in a dose-dependent manner and induced lung fibrosis in vivo. NM400 stimulated the proliferation of all tested fibroblast types, independently of FBS- or BSA- dispersion. Results obtained by WST1 cell activity were confirmed with cell counting and cell cycle (PI staining) assays. Crocidolite also stimulated fibroblast proliferation and induced pulmonary fibrosis, although to a lesser extent than NM400 and NM402. In contrast, shorter CNT (NM400c and MWCNTg 2400) did not induce any fibroblast proliferation or collagen accumulation in vivo, supporting the idea that CNT structure is an important parameter for inducing lung fibrosis.ConclusionsIn this study, an optimized proliferation assay using BSA as a dispersant, MLg cells as targets and an adaptation of WST-1 as readout was developed. The activity of MWCNT in this test strongly reflects their fibrotic activity in vivo, supporting the predictive value of this in vitro assay in terms of lung fibrosis potential.

[1]  Vincent Castranova,et al.  Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. , 2011, ACS nano.

[2]  Paul A Schulte,et al.  Occupational nanosafety considerations for carbon nanotubes and carbon nanofibers. , 2013, Accounts of chemical research.

[3]  K. Mizuno,et al.  Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation , 2012, Nanotoxicology.

[4]  K. Mizuno,et al.  Pulmonary toxicity of well-dispersed single-wall carbon nanotubes after inhalation , 2012, Nanotoxicology.

[5]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[6]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[7]  P. Lebecque,et al.  Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis , 2013, PloS one.

[8]  R. Aitken,et al.  Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[10]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[11]  H. Byrne,et al.  Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity , 2007 .

[12]  Neelam Azad,et al.  Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses , 2013, Nanotoxicology.

[13]  P. Baron,et al.  Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[14]  Jessica Gorman.  Taming high-tech particles , 2002 .

[15]  Vincent Castranova,et al.  Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. , 2010, ACS nano.

[16]  B. van Ravenzwaay,et al.  Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  D. Wallace,et al.  Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. , 2010, American journal of respiratory cell and molecular biology.

[18]  T. Xia,et al.  Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. , 2012, Nano letters.

[19]  Peng Wang,et al.  Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway. , 2013, Small.

[20]  Zongxi Li,et al.  Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. , 2013, ACS nano.

[21]  Liying Wang,et al.  Direct Fibrogenic Effects of Dispersed Single-Walled Carbon Nanotubes on Human Lung Fibroblasts , 2010, Journal of toxicology and environmental health. Part A.

[22]  François Béguin,et al.  Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. , 2008, Chemical research in toxicology.

[23]  Jürgen Pauluhn,et al.  Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  Nianqiang Wu,et al.  Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. , 2010, Toxicology.

[25]  Ivana Fenoglio,et al.  Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials. , 2011, Nanomedicine.

[26]  T. Cui,et al.  Bone formation on carbon nanotube composite. , 2011, Journal of biomedical materials research. Part A.

[27]  E. Crouch,et al.  Pathobiology of pulmonary fibrosis. , 1990, The American journal of physiology.

[28]  Young Hee Lee,et al.  Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. , 2008, Inhalation toxicology.

[29]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Vincent Castranova,et al.  Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies , 2010, Particle and Fibre Toxicology.

[31]  Agnes B Kane,et al.  Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[32]  L. Chiesa,et al.  A new procedure for the specific high-performance liquid chromatographic determination of hydroxyproline. , 1997, Journal of chromatographic science.

[33]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[34]  Hui Hu,et al.  Bone cell proliferation on carbon nanotubes. , 2006, Nano letters.

[35]  J. Nagy,et al.  Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: physicochemical aspects. , 2008, Chemical research in toxicology.

[36]  F. Martinez,et al.  Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.

[37]  J. Nagy,et al.  Respiratory toxicity of multi-wall carbon nanotubes. , 2005, Toxicology and applied pharmacology.

[38]  H W Leung,et al.  Scientific and practical considerations for the development of occupational exposure limits (OELs) for chemical substances. , 1992, Regulatory toxicology and pharmacology : RTP.

[39]  Scott W Burchiel,et al.  Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  N. Monteiro-Riviere,et al.  Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.

[41]  Antonio Marcomini,et al.  In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers , 2012, Nanotoxicology.

[42]  Vincent Castranova,et al.  Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes , 2010, Particle and Fibre Toxicology.

[43]  Bas J Blaauboer,et al.  The applicability of in vitro-derived data in hazard identification and characterisation of chemicals. , 2002, Environmental toxicology and pharmacology.